Crossmark

First-line therapy with LPV/r vs NVP and 2 NRTIs in a developing country: W144 of a randomized trial

Crossref DOI link: https://doi.org/10.1186/1471-2334-14-S2-O2

Published Online: 2014-05-23

Published Print: 2014-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Clumeck, Nathan

Mwamba, Claude

Kabeya, Kabamba

Calvez, Vincent

Matanda, Serge

Vaira, Dolorès

Peytavin, Gilles

Necsoi, Coca

Delforge, Marc

Kadiebwe, David

Milolo, Chantal

Ilunga, Joe

Kapend, Liévin
More Information

Article History

First Online: 23 May 2014